DiaMedica Therapeutics (DMAC) Accumulated Depreciation (2017 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Accumulated Depreciation of $159000.0 for Q1 2026, up 30.33% year-over-year from $122000.0 in Q1 2025, and up 6.0% quarter-over-quarter from $150000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Accumulated Depreciation (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Accumulated Depreciation history runs 10 years deep, the most recent figure standing at $159000.0 for Q1 2026.
- In Q1 2026, Accumulated Depreciation rose 30.33% year-over-year to $159000.0; the TTM figure through Mar 2026 stood at $159000.0 (up 30.33% YoY), while the FY2025 annual figure was $150000.0, up 31.58% from the prior year.
- Accumulated Depreciation for Q1 2026 stood at $159000.0, up from $150000.0 in the prior quarter.
- The five-year high for Accumulated Depreciation was $159000.0 in Q1 2026, with the low at $62000.0 in Q1 2022.
- The 5-year median for Accumulated Depreciation is $100000.0 (2023), against an average of $104117.6.
- The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation climbed 6.19% in 2024, then soared 34.95% in 2025.
- DiaMedica Therapeutics' Accumulated Depreciation stood at $80000.0 in 2022, then climbed by 25.0% to $100000.0 in 2023, then climbed by 14.0% to $114000.0 in 2024, then soared by 31.58% to $150000.0 in 2025, then climbed by 6.0% to $159000.0 in 2026.
- Business Quant data shows DMAC's Accumulated Depreciation at $159000.0 in Q1 2026, $150000.0 in Q4 2025, and $139000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 164,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 150,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Dec 31, 2022 | 80,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Mar 31, 2022 | 62,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 60,000.00 |